Ankita Dadwal

448 citations
8 papers · 331 indexed · h-index 6
Topics
Psoriasis: Treatment and Pathogenesis (3 papers)Advancements in Transdermal Drug Delivery (2 papers)Dermatology and Skin Diseases (2 papers)

In The Last Decade

Ankita Dadwal

6 papers receiving 327 citations

Peers

Ankita Dadwal
Comparison fields: 5 of 77
  • Biomaterials 133
  • Biomedical Engineering 119
  • Molecular Biology 102
  • Materials Chemistry 76
  • Pharmaceutical Science 61
Replace Ziting Cheng with:
Ziting Cheng China
Pallavi Chand India
Russell J. Wilson Australia
Evaristus Chinonso Odoh Nigeria
Surya Prakash Singh India
Beatriz García-Pinel Spain
Guichen Zhou China
Durgaramani Sivadasan Saudi Arabia
Sara Nikoofal‐Sahlabadi Iran
Muhammad Waseem Khan Pakistan
Ankita Dadwal relative to Ziting Cheng China Ziting Cheng's profile →
Citations per field
00.5×1.5×
Ziting Cheng · 1×
Citations per year

Countries citing papers authored by Ankita Dadwal

Since Specialization
Citations

This map shows the geographic impact of Ankita Dadwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankita Dadwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankita Dadwal more than expected).

Fields of papers citing papers by Ankita Dadwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankita Dadwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankita Dadwal. The network helps show where Ankita Dadwal may publish in the future.

Co-authorship network of co-authors of Ankita Dadwal

This figure shows the co-authorship network connecting the top 25 collaborators of Ankita Dadwal. A scholar is included among the top collaborators of Ankita Dadwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankita Dadwal. Ankita Dadwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2 0
3 38
4 6
5 17
6 15
7 237
8 18

About Ankita Dadwal

Ankita Dadwal is a scholar working on Pharmaceutical Science, Toxicology and Dermatology, having authored 8 papers that have together received 331 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Biomaterials (133 citations), Pharmaceutical Science (61 citations) and Drug Discovery (1 citation). Ankita Dadwal has collaborated with scholars based in India, Saudi Arabia and United States. Frequent co-authors include Raj Kumar Narang, Ashish Baldi, Neeraj Mishra, Rahul Kumar Maurya, Pooja A. Chawla, Neeraj Mishra, Bhupinder Kumar, Ravindra K. Rawal, Supandeep Singh Hallan and Nidhi Nidhi. Their work appears in journals such as Current Pharmaceutical Design, Artificial Cells Nanomedicine and Biotechnology and Future Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026